Evotec SE has a consensus price target of $7.17, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Morgan Stanley on August 31, 2023, July 12, 2023, and June 23, 2023. With an average price target of $14 between HC Wainwright & Co., HC Wainwright & Co., and Morgan Stanley, there's an implied 96.91% upside for Evotec SE from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
08/31/2023 | EVO | Buy Now | Evotec | $7.11 | 96.91% | HC Wainwright & Co. | Douglas Tsao | $12 → $14 | Maintains | Buy | Get Alert |
07/12/2023 | EVO | Buy Now | Evotec | $7.11 | 68.78% | HC Wainwright & Co. | Douglas Tsao | → $12 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | EVO | Buy Now | Evotec | $7.11 | 125.04% | Morgan Stanley | James Quigley | $12 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
06/16/2023 | EVO | Buy Now | Evotec | $7.11 | 82.84% | B of A Securities | Derik De Bruin | → $13 | Downgrade | Buy → Neutral | Get Alert |
06/08/2023 | EVO | Buy Now | Evotec | $7.11 | — | Citigroup | Peter Verdult | — | Upgrade | Neutral → Buy | Get Alert |
04/04/2023 | EVO | Buy Now | Evotec | $7.11 | — | Morgan Stanley | James Quigley | — | Upgrade | Underweight → Equal-Weight | Get Alert |
03/29/2023 | EVO | Buy Now | Evotec | $7.11 | 68.78% | HC Wainwright & Co. | Douglas Tsao | → $12 | Reiterates | → Buy | Get Alert |
01/27/2023 | EVO | Buy Now | Evotec | $7.11 | 68.78% | HC Wainwright & Co. | Douglas Tsao | → $12 | Reiterates | → Buy | Get Alert |
12/09/2022 | EVO | Buy Now | Evotec | $7.11 | 68.78% | HC Wainwright & Co. | Douglas Tsao | → $12 | Initiates | → Buy | Get Alert |
11/16/2022 | EVO | Buy Now | Evotec | $7.11 | — | Deutsche Bank | Falko Friedrichs | — | Downgrade | Buy → Hold | Get Alert |
08/10/2022 | EVO | Buy Now | Evotec | $7.11 | 125.04% | Morgan Stanley | James Quigley | → $16 | Downgrade | Overweight → Underweight | Get Alert |
11/29/2021 | EVO | Buy Now | Evotec | $7.11 | — | Cowen & Co. | Max Masucci | — | Initiates | → Outperform | Get Alert |
The latest price target for Evotec (NASDAQ: EVO) was reported by HC Wainwright & Co. on August 31, 2023. The analyst firm set a price target for $14.00 expecting EVO to rise to within 12 months (a possible 97.18% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Evotec (NASDAQ: EVO) was provided by HC Wainwright & Co., and Evotec maintained their buy rating.
The last upgrade for Evotec SE happened on June 23, 2023 when Morgan Stanley raised their price target to $16. Morgan Stanley previously had an equal-weight for Evotec SE.
The last downgrade for Evotec SE happened on June 16, 2023 when B of A Securities changed their price target from N/A to $13 for Evotec SE.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evotec, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evotec was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.
While ratings are subjective and will change, the latest Evotec (EVO) rating was a maintained with a price target of $12.00 to $14.00. The current price Evotec (EVO) is trading at is $7.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.